Company: Life Biosciences
Job title: Chief Executive Officer
Mehmood Khan, MD, is Chief Executive Officer and Board Member of Life Biosciences Inc. Founded in 2017 and headquartered in Boston, Life Biosciences is a biotechnology company developing therapies for age-related diseases by focusing on the biology of aging.
Dr. Khan previously served as Vice Chairman and Chief Scientific Officer of Global Research and Development at PepsiCo, a Fortune 50 company with 250,000+ employees across 22 brands. Prior to that, he was President of Global R&D Center at Takeda Pharmaceuticals, leading the global efforts of one of the largest pharmaceutical companies in the world by revenue.
Before moving into industry, he had a distinguished medical career as a faculty member in endocrinology at the Mayo Clinic and Mayo Medical School where he served as Director of the Diabetes, Endocrine and Nutritional Trials Unit. He also spent nine at Minneapolis’s Hennepin County Medical Center.
Dr. Khan earned his medical degree from the University of Liverpool Medical School, England and completed a fellowship in clinical endocrinology and nutrition in the Department of Medicine and Food Science and Nutrition at the University of Minnesota. He is a Fellow of the Royal College of Physicians, London as well as the American College of Endocrinology.
Panel Discussion: Recognize the Financial Difficulty of Developing Drugs for Targeting Mitochondria & Moving Drugs to the Next Phase 12:00 pm
• Explore the challenges of funding development • Learn how drug developers can inspire and attract companies to invest in their novel development and pipeline • Discover how can the industry come together to overcome the paucity of fundingRead more
day: Day Two
Novel Mitochondrial Uncoupler Therapeutics & Beyond 12:15 pm
Novel Mitochondrial Uncoupler Therapeutics &Beyond Examine new generation “smart-design” mitochondrial uncouplers Enable technology to treat age-related diseases Understand transformative therapies for metabolic diseases and tissue injuryRead more
day: Day One